Price range:  1-2 containers: $18.95 each.     3-5: $17.95    6+: $16.95

               

SPECIAL OFFER!

RECEIVE A FREE PRODUCT
WITH EACH ORDER

(We will send you a free product every time you place an order.)

Have a Healthy & Prosperous Year!

      

 

 

Quality Assurance: This product is manufactured in the United States by one of America's leading laboratories in business since 1955. It is produced from natural sources and contains no yeast, sugar, starch, artificial flavor, dyes, coloring agent or preservatives.

 

Flax Seed Oil is rich in alpha-linolenic acid (ALA), an essential omega-3 fatty acid which is vital to overall good health.  Omega-3 fatty acids are important because they counterbalance the inflammatory effects of Omega-6 fatty acids. 

In modern developed countries, typical diets contain an unhealthy ratio of Omega-6 to Omega-3 fatty acids –most American diets contain more than fifteen times as many Omega-6 fatty acids than Omega-3. 

This imbalance is believed to be related to the rise in heart disease, high blood pressure, and high cholesterol in the United States.  Consuming vegetable oils and fish oils rich in Omega-3 fatty acids is essential for restoring the natural balance within the body and for preventing these diseases.

 

(Click for Ingredients Listing)

 

 

(Click to Read What the University of Maryland Medical Center has to Say about Flax Seed Oil.)

 

(Click to Read What the Mayo Clinic Has to Say about Flax Seed Oil)

Flax Seed Oil contains about 55% ALA.  As an anti-inflammatory substance, ALA prevents platelets in the blood from forming harmful clots through aggregation.  The process of platelet aggregation, however, is an essential function of the body because it is by this process that bleeding from wounds is stopped and healing begins.  It is therefore vitally important to maintain a healthy ratio of omega-6 and omega-3 fatty acids, since too much omega-3 can diminish the body’s ability to heal its wounds, and too much omega-6 may cause blood clots to form in the bloodstream. 

Consuming an unhealthy imbalance of these important nutrients can increase the risk of heart attack and stroke.  Supplementation with Flax Seed Oil may help restore a healthy balance of omega-3 and omega-6 fatty acids.

Other benefits of Flax Seed Oil include the treatment of arthritis, atherosclerosis, and inflammatory bowel diseases.  In addition, Flax Seed Oil may improve cognitive function.  Some research suggests that people with diets low in omega-3 fatty acids are at increased risk for depression.  Patients with ADHD have seen some decrease in symptoms with ALA supplementation. 

 

Return to Top of Page

 

 

The University of Maryland Medical Center
lists the following uses for Flax Seed Oil:

“Studies suggest that Flax Seed Oil and other Omega-3 fatty acids may be helpful in treating a variety of conditions. The evidence is strongest for heart disease and problems that contribute to heart disease, but the range of possible uses for Flax Seed Oil include:

HIGH CHOLESTEROL
“People who follow a Mediterranean diet tend to have higher HDL ("good") cholesterol levels. The Mediterranean diet consists of a healthy balance between Omega-3 and Omega-6 fatty acids. It emphasizes whole grains, root and green vegetables, daily intake of fruit, fish and poultry, olive and canola oils, and ALA, along with discouragement of ingestion of red meat and total avoidance of butter and cream.

HIGH BLOOD PRESSURE
“Several studies suggest that diets and/or supplements rich in omega-3 fatty acids (including ALA) lower blood pressure significantly in people with hypertension. Fish high in mercury (such as tuna) should be avoided, however, because they may increase blood pressure.

HEART DISEASE
“One of the best ways to help prevent and treat heart disease is to eat a low-fat diet and to replace foods rich in saturated and trans-fat with those that are rich in monounsaturated and polyunsaturated fats (including omega-3 fatty acids from Flax Seed Oil). Evidence suggests that people who eat an ALA-rich diet are less likely to suffer a fatal heart attack.

INFLAMMATORY BOWEL DISEASE (IBD)
“Some people with Crohn's disease (CD), one form of IBD, have low levels of omega-3 fatty acids in their bodies. Fish oil supplements containing omega-3 fatty acids have been shown to reduce symptoms of CD and ulcerative colitis (another inflammatory bowel disease), particularly if used in addition to medication. Preliminary animal studies have found that ALA (such as from Flax Seed Oil) may actually be more effective than EPA and DHA found in fish oil supplements, but further studies in humans are needed to confirm these findings.

ARTHRITIS
“Several studies suggest that omega-3 fatty acid supplements reduce tenderness in joints, decrease morning stiffness, and allow for a reduction in the amount of medication needed for people with rheumatoid arthritis and, probably, osteoarthritis as well.

BREAST CANCER
“Women who regularly consume foods rich in omega-3 fatty acids over many years may be less likely to develop breast cancer and to die from the disease than women who do not follow such a diet. Laboratory and animal studies indicate that omega-3 fatty acids can inhibit the growth of human breast cancer cells and may even prevent the spread of cancer to other parts of the body. Several experts speculate that omega-3 fatty acids in combination with other nutrients (namely, vitamin C, vitamin E, beta-carotene, selenium, and coenzyme Q10) may prove to be of particular value for preventing and treating breast cancer.

DEPRESSION
“People who do not get enough omega-3 fatty acids or do not maintain a healthy balance of omega-3 to omega-6 fatty acids in their diet may be at an increased risk for depression. The omega-3 fatty acids are important components of nerve cell membranes. They help nerve cells communicate with each other, which is an essential step in maintaining good mental health.

BURNS
“Essential fatty acids have been used to reduce inflammation and promote wound healing in burn victims. Animal research indicates that omega-3 fatty acids help promote a healthy balance of proteins in the body -- protein balance is important for recovery after sustaining a burn. Further research is necessary to determine if this may apply to people as well.

ACNE
“Although there are few studies to support the use of omega-3 fatty acids for skin problems, many clinicians believe that flaxseed is helpful for treating acne.

ASTHMA
“Preliminary research suggests that omega-3 fatty acid supplements may decrease inflammation and improve lung function in adults with asthma.

MENSTRUAL PAIN
“In a study of nearly 200 Danish women, those with the highest dietary intake of omega-3 fatty acids had the mildest symptoms during menstruation.

OTHER
“Although further research is needed, preliminary evidence suggests that omega-3 fatty acids may also prove helpful in protecting against certain infections and treating a variety of conditions including ulcers, migraine headaches, preterm labor, emphysema, psoriasis, glaucoma, Lyme disease, lupus, and panic attacks.”

Contraindications:
Women who are pregnant should not use supplemental Flax Seed Oil or flax seed because of the theoretical possibility that these lignan-containing substances might induce menstruation.

Infants, young children, and nursing mothers should avoid supplemental Flax Seed Oil. Because of possible antithrombotic activity, those with hemophilia and those taking warfarin should be cautious about the use of supplemental flax Seed Oil or flaxseed. Flax Seed Oil intake should be halted in those having surgical procedures.

Return to Top of Page

Research:

“Reducing atherogenic risk in hyperlipemic humans with flax seed supplementation: a preliminary report.”
Bierenbaum, M L : Reichstein, R : Watkins, T R
J-Am-Coll-Nutr. 1993 Oct; 12(5): 501-4
The effect on serum lipids of a flax seed supplement consisting of three slices of flax seed-containing bread and 15 g of ground flax seed was studied in 15 hyperlipemic subjects on long-term intake (800 IU/day) of vitamin E. The flax seed, which was high in alpha-linolenic acid and fiber, and which has been reported to lower serum cholesterol in elderly subjects, was provided in a 3-month feeding trial. Serum total and low-density lipoprotein cholesterol levels were reduced significantly; high-density lipoprotein cholesterol did not change during flax seed consumption. Thrombin-stimulated platelet aggregation decreased with the supplement. Serum lipid oxidation products decreased significantly during the washout period.

“Dietary flax seed in prevention of hypercholesterolemic atherosclerosis.”
 Prasad, K
Atherosclerosis. 1997 Jul 11; 132(1): 69-76
Oxygen free radicals (OFRs) have been implicated in the development of hypercholesterolemic atherosclerosis. Flax seed is the richest source of omega-3 fatty acid and lignans. omega-3 Fatty acid suppresses the production of interleukin-1 (IL-1), tumor necrosis factor (TNF) and leukotriene B4 (LTB4), and of OFRs by polymorphonuclear leukocytes (PMNLs) and monocytes. Lignans possess anti-platelet activating factor (PAF) activity and are antioxidant. PAF, IL-1, TNF and LTB4 are known to stimulate PMNLs to produce OFRs. Flaxseed would, therefore, reduce the levels of OFRs and hence would prevent the development of hypercholesterolemic atherosclerosis. The effects of dietary flax seed on a high cholesterol diet induced atherosclerosis, lipid profile and OFR-producing activity of PMNLs (PMNL-CL) were investigated in rabbits. The rabbits were divided into 4 groups: group I, control; group II, flax seed diet (7.5 g/kg daily, orally); group III, 1% cholesterol diet; and group IV, same as group III but received flax seed (7.5 g/kg daily, orally). Blood samples were collected before and after 4 and 8 weeks on their respective diets for biochemical measurements and aortae were removed at the end of 8 weeks for estimation of atherosclerotic changes. The high cholesterol diet increased the serum level of total cholesterol (TC) and PMNL-CL without altering the levels of serum triglycerides (TG). These changes were associated with a marked development of atherosclerosis in the aorta. Flax seed reduced the development of aortic atherosclerosis by 46% and reduced the PMNL-CL without significantly lowering the serum cholesterol. Flax seed in normocholesterolemic rabbits increased serum total cholesterol and decreased PMNL-CL without significantly affecting the serum TG. Modest dietary flax seed supplementation is effective in reducing hypercholesterolemic atherosclerosis markedly without lowering serum cholesterol. Its effectiveness against hypercholesterolemic atherosclerosis could be due to suppression of enhanced production of OFRs by PMNLs in hypercholesterolemia. Dietary flax seed supplementation could, therefore, prevent hypercholesterolemia-related heart attack and strokes.

“Effect of dietary flax oil and hypobaric hypoxia on right ventricular hypertrophy and ascites in broiler chickens.”
Bond, J M : Julian, R J : Squires, E J
Br-Poult-Sci. 1996 Sep; 37(4): 731-41
1. The effect of dietary flax oil on growth rate, blood haemoglobin content, mortality and incidence of pulmonary hypertension and ascites in broilers at ambient pressure and at reduced atmospheric pressure was examined. 2. Birds were housed either in hypobaric chambers simulating 1000, 1500 or 2200 m altitude or in pens at ambient atmospheric pressure and fed on diets containing 100 g/kg added fat as either an animal/vegetable (A/V) blend or flax oil. 3. Birds raised under hypobaric conditions had a decreased growth rate and increased mortality, blood haemoglobin content, and incidence of pulmonary hypertension and ascites compared to the groups at normal atmospheric pressure. 4. Broilers fed on the diet containing flax oil showed no difference in growth rate or blood haemoglobin content compared to birds fed on the A/V fat diet raised at the same altitude. 5. Inclusion of flax oil in the diet decreased mortality and the incidence of ascites at 2200 m and pulmonary hypertension at 1500 m. 6. Flax oil may be an effective method of reducing ascites and pulmonary hypertension in broilers without affecting performance.

 

Addition Information Compiled by the Mayo Clinic:

Uses based on scientific evidence 

ATTENTION DEFICIT HYPERACTIVITY DISORDER
Preliminary evidence supports the idea that deficiencies or imbalances in certain highly unsaturated fatty acids may contribute to attention deficit hyperactivity disorder (ADHD). Based on one trial, alpha linolenic acid (ALA)-rich nutritional supplementation in the form of flax oil may improve symptoms of ADHD. More research is needed to confirm these results.
    
HEART DISEASE
People who have had a heart attack are reported to benefit from diets rich in alpha-linolenic acid, which is found in flax seed. Good studies that examine the effect of flax seed on heart disease in humans are not available. It is unclear whether flax seed supplementation alters the course of heart disease.
       
HIGH CHOLESTEROL OR TRIGLYCERIDES
In laboratory and animal studies, flax seed and Flax Seed Oil are reported to lower blood cholesterol levels. Effects on blood triglyceride levels in animals are unclear, with increased levels in some research, and decreased levels in other research. Human studies in this area report mixed results, with decreased blood levels of total cholesterol and low-density lipoprotein ("bad cholesterol") in some studies, but no effect in other studies. Most human research has not been well-designed, and further research is needed before a recommendation can be made.  

MENOPAUSAL SYMPTOMS
There is preliminary evidence from randomized controlled trials that Flax Seed Oil may help decrease mild menopausal symptoms. Additional research is necessary before a clear conclusion can be drawn and this remains an area of controversy. Patients should consult a doctor and pharmacist about treatment options before starting a new therapy. Overall effects on bone mineral density and lipid profiles remain unclear.    
 

Precautions and Possible Interactions:

Do not take Flax Seed Oil at the same time with other medications, as flax seed may slow the obsorption of some oral medications. 

ALA in Flax Seed Oil is converted to EPA and DHA, forms more readily useable to the body.  People with diabetes or schizophrenia may not be able to perform this conversion, so they should obtain omega-3 acids in forms rich in EPA and DHA.

A recent study showed that diets containing a large amount of ALA may aggravate the symptoms of macular degeneration, even though a diet high in fish, a rich source of ALA, has been shown to reduce the risk of macular degeneration.   People with this disease should be mindful of this risk.

Similarly, although fish have been proven to reduce the risk of prostate cancer, excessive amounts of ALA may actually increase this risk. 

If you are taking any blood-thinning medications, speak with your doctor before supplementing with Flax Seed Oil.  In some cases, flax seed may assist these drugs, in other cases, they may cause harmful conditions.

Flax Seed Oil supplementation has been shown to assist the effects of some medications. 
A healthy balance of omega-3 to omega-6 fatty acids, for example, may improve the effectiveness of cholesterol-lowering medications.  Omega-3 fatty acids may reduce the harmful side effects of Cyclosporine therapy, as well as those harmful side effects which are associated with Non-steroidal anti-inflammatory drugs (NSAIDs).

References:
Anonymous. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 8-7-1999;354(9177):447-455.
Brooks, J. D., Ward, W. E., Lewis, J. E., Hilditch, J., Nickell, L., Wong, E., and Thompson, L. U. Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. Am J Clin Nutr 2004;79(2):318-325.
Dabrosin, C., Chen, J., Wang, L., and Thompson, L. U. Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts. Cancer Lett 11-8-2002;185(1):31-37.
Dalais, F. S., Meliala, A., Wattanapenpaiboon, N., Frydenberg, M., Suter, D. A., Thomson, W. K., and Wahlqvist, M. L. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer. Urology 2004;64(3):510-515.
Demark-Wahnefried, W., Price, D. T., Polascik, T. J., Robertson, C. N., Anderson, E. E., Paulson, D. F., Walther, P. J., Gannon, M., and Vollmer, R. T. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 2001;58(1):47-52.
Dodin, S., Lemay, A., Jacques, H., Legare, F., Forest, J. C., and Masse, B. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin.Endocrinol.Metab 2005;90(3):1390-1397.
Goss PE, Li T, Theriault M, and et al. Effects of dietary flaxseed in women with cyclical mastalgia. Breast Cancer Res Treat 2000;64:49.
Hu, F. B., Stampfer, M. J., Manson, J. E., Rimm, E. B., Wolk, A., Colditz, G. A., Hennekens, C. H., and Willett, W. C. Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr 1999;69(5):890-897.
Joshi K, Lad S, Kale M, Patwardhan B, Mahadik SP, Patni B, Chaudhary A, Bhave S, Pandit A. Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD). Prostaglandins Leukot Essent Fatty Acids. 2006 Jan;74(1):17-21.
Lemay, A., Dodin, S., Kadri, N., Jacques, H., and Forest, J. C. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet.Gynecol. 2002;100(3):495-504.
Prasad, K., Mantha, S. V., Muir, A. D., and Westcott, N. D. Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis 1998;136(2):367-375.
Stoll, A. L., Severus, W. E., Freeman, M. P., Rueter, S., Zboyan, H. A., Diamond, E., Cress, K. K., and Marangell, L. B. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen.Psychiatry 1999;56(5):407-412.
von Schacky, C., Angerer, P., Kothny, W., Theisen, K., and Mudra, H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 4-6-1999;130(7):554-562.
Young GS, Conquer JA, Thomas R. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder. Reprod Nutr Dev. 2005 Sep-Oct;45(5):549-58.
Angerer P, von Schacky C. n-3 polyunsaturated fatty acids and the cardiovascular system. Curr Opin Lipidol. 2000;11(1):57-63.
Appel LJ. Nonpharmacologic therapies that reduce blood pressure: a fresh perspective. Clin Cardiol. 1999;22(Suppl. III):III1-III5.
Arnold LE, Kleykamp D, Votolato N, Gibson RA, Horrocks L. Potential link between dietary intake of fatty acid and behavior: pilot exploration of serum lipids in attention-deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 1994;4(3):171-182.
Baumgaertel A. Alternative and controversial treatments for attention-deficit/hyperactivity disorder. Pediatr Clin of North Am. 1999;46(5):977-992.
Belluzzi A, Boschi S, Brignola C, Munarini A, Cariani C, Miglio F. Polyunsaturated fatty acids and inflammatory bowel disease. Am J Clin Nutr. 2000;71(suppl):339S-342S.
Billeaud C, Bougle D, Sarda P, et al. Effects of preterm infant formula supplementation with alpha-linolenic acid with a linoleate/alpha-linoleate ration of 6. Eur J Clin Nutr. August 1997;51:520–527.
Boelsma E, Hendriks HF. Roza L. Nutritional skin care: health effects of micronutrients and fatty acids. Am J Clin Nutr. 2001;73(5):853-864.
Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, Ore: Eclectic Medical; 1998:71-72.
Brown DJ, Dattner AM. Phytotherapeutic approaches to common dermatologic conditions. Arch Dermatol. 1998;134:1401-1404.
Bruinsma KA, Taren DL. Dieting, essential fatty acid intake, and depression. Nutr Rev. 2000;58(4):98-108.
Burgess J, Stevens L, Zhang W, Peck L. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am J Clin Nutr. 2000; 71(suppl):327S-330S.
Caron MF, White CM. Evaluation of the antihyperlipidemic properties of dietary supplements. Pharmacotherapy. 2001;21(4):481-487.
Clark WF, Kortas C, Heidenheim AP, Garland J, Spanner E, Parbtani A. Flaxseed in lupus nephritis: a two–year nonplacebo-controlled crossover study. J Am Coll Nutr. 2001;20(2 Suppl):143-148.
Curtis CL, Hughes CE, Flannery CR, Little CB, Harwood JL, Caterson B. N-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem. 2000;275(2):721-724.
Cho E, Hung S, Willett WC, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr. 2001;73(2):209-218.
Danao-Camara TC, Shintani TT. The dietary treatment of inflammatory arthritis: case reports and review of the literature. Hawaii Med J. 1999;58(5):126-131.
DeDeckere EA, Korver O, Verschuren PM, Katan MB. Health aspects of fish and n-3 polyunsaturated fatty acids from plant and marine origin. Eur J Clin Nutr. 1998;52:749–753.
de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343:1454–1459.
de Logeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99(6):779-785.
De-Souza DA, Greene LJ. Pharmacological nutrition after burn injury. J Nutr. 1998;128:797-803.
Deutch B. Menstrual pain in Danish women correlated with low n-3 polyunsaturated fatty acid intake. Eur J Clin Nutr. 1995;49(7):508-516.
Dichi I, Frenhane P, Dichi JB, et al. Comparison of omega-3 fatty acids and sulfasalazine in ulcerative colitis. Nutrition. 2000;16:87-90.
Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord. 1998;48:149–155.
Frieri G, Pimpo MT, Palombieri A, et al. Polyunsaturated fatty acid dietary supplementation: an adjuvant approach to treatment of Helicobacter pylori infection. Nutr Res. 2000;20(7):907-916.
Geerling BJ, Badart-Smook A, van Deursen C, et al. Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile. Inflamm Bowel Dis. 2000;6(2):77-84.
Geerling BJ, Houwelingen AC, Badart-Smook A, Stockbrügger RW, Brummer R-JM. Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn's disease, compared with controls. Am J Gastroenterol. 1999;94(2):410-417.
Gibson SL, Gibson RG. The treatment of arthritis with a lipid extract of Perna canaliculus: a randomized trial. Complement Ther Med. 1998;6:122-126.
GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447-455.
Halpern G-M. Anti-inflammatory effects of a stabilized lipid extract of Perna canaliculus (Lyprinol). Allerg Immunol (Paris). 2000;32(7):272-278.
Harris WS. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65:1645S-1654S.
Harper CR, Jacobson TA. The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med. 2001;161(18):2185-2192.
Hayashi N, Tsuguhiko T, Yamamori H, et al. Effect of intravenous omega-6 and omega-3 fat emulsions on nitrogen retention and protein kinetics in burned rats. Nutrition. 1999;15(2):135-139.
Hibbeln JR, Salem N, Jr. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr. 1995;62(1):1-9.
Horrobin DF. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res. 1998;30(3):193-208.
Horrobin DF, Bennett CN. Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Prostaglandins Leukot Essent Fatty Acids. 1999;60(4):217-234.
Hrboticky N, Zimmer B, Weber PC. Alpha-Linolenic acid reduces the lovastatin-induced rise in arachidonic acid and elevates cellular and lipoprotein eicosapentaenoic and docosahexaenoic acid levels in Hep G2 cells. J Nutr Biochem. 1996;7:465-471.
Hu FB, Stampfer MJ, Manson JE et al. Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr. 1999;69:890-897.
The International Society for the Study of Fatty Acids and Lipids (ISSFAL). Recommendations for the essential fatty acid requirement for infant formulas (policy statement). Available at: http://www.issfal.org.uk/. Accessed January 17, 2001.
Jeschke MG, Herndon DN, Ebener C, Barrow RE, Jauch KW. Nutritional intervention high in vitamins, protein, amino acids, and omega-3 fatty acids improves protein metabolism during the hypermetabolic state after thermal injury. Arch Surg. 2001;136:1301-1306.
Juhl A, Marniemi J, Huupponen R, Virtanen A, Rastas M, Ronnemaa T. Effects of diet and simvistatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men; a randomized controlled trial. JAMA. 2002;2887(5):598-605.
Krauss RM, Eckel RH, Howard B, et al. AHA Scientific Statement: AHA dietary guidelines revision 2000: A statement for healthcare professionals from the nutrition committee of the American Heart Association. Circulation. 2000;102(18):2284-2299.
Kremer JM. N-3 fatty acid supplements in rheumatoid arthritis. Am J Clin Nutr. 2000;(suppl 1):349S-351S.
Kris-Etherton P, Eckel RH, Howard BV, St. Jeor S, Bazzare TL. AHA science advisory: Lyon diet heart study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I dietary pattern on cardiovascular disease. Circulation. 2001;103:1823.
Kris-Etherton PM, Taylor DS, Yu-Poth S. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr. 2000;71(1):179-188.
Kuroki F, Iida M, Matsumoto T, Aoyagi K, Kanamoto K, Fujishima M. Serum n3 polyunsaturated fatty acids are depleted in Crohn's disease. Dig Dis Sci. 1997;42(6):1137-1141.
Lockwood K, Moesgaard S, Hanioka T, Folkers K. Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids, and coenzyme Q10. Mol Aspects Med. 1994;15Suppl:s231-s240.
Lorenz-Meyer H, Bauer P, Nicolay C, et al. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group). Scan J Gastroenterol. 1996;31(8):778-785.
McGuffin M, Hobbs C, Upton R, et al, eds. Botanical Safety Handbook. Boca Raton, Fla: CRC Press; 1997.
Mayser P, Mrowietz U, Arenberger P, et al. Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo controlled, multicenter trial. J Am Acad Dermatol. 1998;38(4):539-547.
Mitchell EA, Aman MG, Turbott SH, Manku M. Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clin Pediatr (Phila). 1987;26:406-411.
Nestel PJ, Pomeroy SE, Sasahara T, et al. Arterial compliance in obese subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increased LDL oxidizability. Arterioscler Thromb Vasc Biol. July 1997;17(6):1163-1170.
Newcomer LM, King IB, Wicklund KG, Stanford JL. The association of fatty acids with prostate cancer risk. Prostate. 2001;47(4):262-268.
Okamoto M, Misunobu F, Ashida K, Mifune T, Hosaki Y, Tsugeno H, et al. Effects of dietary supplementation with n-3 fatty acids compared with n-6 fatty acids on bronchial asthma. Int Med. 2000;39(2):107-111.
Okamoto M, Misunobu F, Ashida K, et al. Effects of perilla seed oil supplementation on leukotriene generation by leucocytes in patients with asthma associated with lipometabolism. Int Arch Allergy Immunol. 2000;122(2):137-142.
Prasad K. Dietary flaxseed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis. 1997;132(1):69–76.
Prisco D, Paniccia R, Bandinelli B, et al. Effect of medium term supplementation with a moderate dose of n-3 polyunsaturated fatty acid on blood pressure in mild hypertensive patients. Thromb Res. 1998;91:105-112.
Richardson AJ, Puri BK. The potential role of fatty acids in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids. 2000;63(1/2):79-87.
Shils ME, Olson JA, Shike M, Ross AC. Modern Nutrition in Health and Disease. 9th ed. Baltimore, Md: Williams & Wilkins; 1999:90-92, 1377-1378.
Shoda R, Matsueda K, Yamato S, Umeda N. Therapeutic efficacy of N-3 polyunsaturated fatty acid in experimental Crohn's disease. J Gastroenterol. 1995;30(Suppl 8):98-101.
Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr. 1999;70(30 Suppl):560S-569S.
Simopoulos AP. Human requirement for N-3 polyunsaturated fatty acids. Poult Sci. 2000;79(7):961-970.
Soyland E, Funk J, Rajka G, Sandberg M, Thune P, Ruistad L, et al. Effect of dietary supplementation with very-long chain n-3 fatty acids in patients with psoriasis. N Engl J Med. 1993;328(25):1812-1816.
Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Eng J Med. 2000;343(1):16-22.
Stevens LJ, Zentall SS, Abate ML, Kuczek T, Burgess JR. Omega-3 fatty acids in boys with behavior, learning and health problems. Physiol Behav. 1996;59(4/5):915-920.
Stoll BA. Breast cancer and the Western diet: role of fatty acids and antioxidant vitamins. Eur J Cancer. 1998;34(12):1852-1856.
Talom RT, Judd SA, McIntosh DD, et al. High flaxseed (linseed) diet restores endothelial function in the mesenteric arterial bed of spontaneously hypertensive rats. Life Sci. 1999;16:1415–1425.
Terry P, Lichtenstein P, Feychting M, Ahlbom A, Wolk A. Fatty fish consumption and risk of prostate cancer. Lancet. 2001;357(9270):1764-1766.
Tsujikawa T, Satoh J, Uda K, Ihara T, Okamoto T, Araki Y, et al. Clinical importance of n-3 fatty acid-rich diet and nutritional education for the maintenance of remission in Crohn's disease. J Gastroenterol. 2000;35(2):99-104.
von Schacky C, Angere P, Kothny W, Theisen K, Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;130:554-562.
Voskuil DW, Feskens EJM, Katan MB, Kromhout D. Intake and sources of alpha-linolenic acid in Dutch elderly men. Eur J Clin Nutr. 1996;50:784–787.
Yehuda S, Rabinovitz S, Carasso RL, Mostofsky DI. Fatty acids and brain peptides. Peptides. 1998;19:407–419.
Zambón D, Sabate J, Munoz S, et al. Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. Ann Intern Med. 2000;132:538-546.
Zimmerman R, Radhakrishnan J, Valeri A, Appel G. Advances in the treatment of lupus nephritis. Annu Rev Med. 2001;52:63-78.

 

RETURN TO TOP OF PAGE

 

RETURN TO HOME PAGE

 

 

 

 

 

 

 

flaxseed oil

omega 3

flax seed oil

Good Health Group of America
www.goodhealthco.com